LDC invests in Panthera Biopartners to accelerate expansion
Summary
LDC has invested in Panthera Biopartners to help the company expand its clinical trial operations in the UK and Europe. Panthera runs commercial clinical trials and specializes in patient recruitment, trial delivery, data collection, and retention support. The company works with major pharmaceutical firms and CROs and plans to add more sites, invest in technology, and scale its services. The deal also marks an exit for BGF and Gresham House Ventures, while BGF will reinvest as a minority shareholder.
Funding
Amount
None
Total raised
Date
August 12, 2025
Announcement date
Investors
Gresham House Ventures, LDC, TDC, BGF, DLA Piper, DWF
Lead investors
Company
-
Funded company
Classifications
industries
No industries detected
applications
No applications detected
AskAI Classifications
Labels
No AI classifications detected